A new medical study offers good news for expectant mothers facing the difficult choice of treating the nausea and vomiting of early pregnancy with things like soda, crackers or crushed ice, which are only marginally helpful, or trying prescription or over-the-counter medications, which may have potential side effects.
The September/October issue of Alternative Therapies in Health and Medicine features results from a new double-blind, placebo-controlled, and hospital-based study conducted by obstetricians Angela Keating, M.D. and Ronald Chez, M.D., which indicates that Ginger Honey Tonic, a potency-assured formulation manufactured by New Chapter, Inc., is a safe and effective way to treat nausea and vomiting associated with morning sickness.
In an article entitled, "Ginger Syrup as an Antiemetic in Early Pregnancy," Dr. Keating and Dr. Chez summarize results of a study they conducted over a six-month period with women ages 24-37 in their first twelve weeks on pregnancy. In the study, women were chosen at random to use New Chapters Ginger Honey Tonic or a "placebo" syrup. Neither group of women was aware of the use of the placebo product. They were asked to rate their symptoms and how they felt on a 10-point scale at regular intervals The study found significant reductions in both nausea and vomiting in the group using the Ginger Honey Tonic vs. the placebo-control group. For example, 77% of the Ginger Honey Tonic group experienced a dramatic 4-point or greater improvement on the nausea scale within 9 days. These findings led the researchers to conclude that "1 g of ginger in syrup or capsules ingested daily in divided doses appears to be a reasonable and safe option in the treatment of nausea in early pregnancy." Equally important, there were no contraindications to the suggested use of New Chapters Ginger Honey Tonic during pregnancy.
Melinda Walsh | EurekAlert!
Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg
In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.
Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...
An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...
Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.
Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
04.06.2020 | Life Sciences
04.06.2020 | Physics and Astronomy
04.06.2020 | Life Sciences